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Objective: Evaluate hemostatic dysfunction in pediatric severe sepsis by
thromboelastography (TEG) and determine if TEG parameters are associated with
new or progressive multiple organ dysfunction syndrome (NPMODS) or shock, defined
as a lactate ≥2mmol/L. We explored the relationship between TEG variables, selective
cytokines, and endothelial factors.
Design: Prospective observational.
Setting: Single-center, quaternary care pediatric intensive care unit.
Patients: Children aged 6- months to 14- years with severe sepsis with expected PICU
stay for >72 h.
Interventions: None.
Measurements and Main Results: Twenty-eight children were enrolled with median
(IQR) age of 7.3 years (4.4–11.4), PELOD score (study day-1) of 11(1.25–13), and
PICU length of stay of 10 days (5–28). TEG-defined hypercoagulable state occurred
most commonly in 73% (94/129) of samples, followed by hypocoagulable state in 7.8%
(10/129) and mixed coagulation state in 1.5% (2/129) of samples in the study cohort. In
contrast, hypocoagulable state occurred most commonly in 66% (98/148) of samples
based on standard coagulation parameters. In the seven children who developed shock
with NPMODS compared to eight patients with shock without NPMODS and 12 patients
with severe sepsis only, we found more profound coagulopathy [thrombocytopenia (p
= 0.04), elevated INR (p = 0.038), low fibrinogen level (p = 0.049), and low TEG-G
value (p = 0.01)] and higher peak of interleukin-6 (p = 0.0014) and IL-10 (p = 0.007).
Peak lactate in the first 5 study days had moderate correlation with standard coagulation
assays, TEG parameters, and selective cytokines. Peak lactate did not correlate with
markers of endothelial activation. Lowest TEG -G value had moderate correlation with
peak IL-10 (ρ −0.442, p = 0.019), peak VCAM (ρ −0.495, p = 0.007), and peak lactate
(ρ −0.542, p = 0.004) in the first 5 study days. A combination of TEG-G value and IL-6
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concentration best discriminated children with shock and NPMODS [AUC 0.979 (95%CI
0.929–1.00), p < 0.001].
Conclusion: This exploratory analysis of hemostasis dysfunction on TEG in pediatric
severe sepsis suggests that while hypercoagulability is more common, a hypocoagulable
state is associated with shock and NPMODS. In addition, TEG abnormalities are also
associated with immune and endothelial factors. A larger cohort study is needed to
validate these findings.
Keywords: thromboelastography, coagulopathy, thrombocytopenia, severe sepsis, shock, multiorgan failure,
pediatric
INTRODUCTION
Pediatric severe sepsis is defined as sepsis with evidence of
dysfunction in two or more organ systems with the presence
of cardiovascular dysfunction defining septic shock (1). Both
severe sepsis and septic shock correlate with activation of
immune, endothelial, and hemostatic systems (2–4). Classically,
a hypercoagulable state with or without hyperfibrinolysis has
been associated with thrombotic microangiopathies caused
by diffuse microvascular thrombi or early Disseminated
Intravascular Coagulation (DIC) (5). With DIC in particular, as
hypercoagulability and clotting factor consumption continues, a
hypocoagulable state develops with increased risk of bleeding due
to the depletion of coagulation factors and thrombocytopenia (4).
Sepsis-related hypocoagulability has been associated with
cardiovascular dysfunction and shock in adults and children (2,
3). Unlike in acute traumatic injury where tissue hypoperfusion
and shock have been reported to contribute independently to
hypocoagulability and increased risk of death in both adults and
children (6–9), the causative mechanisms of how septic shock
affects hemostatic dysfunction have not been as well-defined
or demonstrated. A more thorough understanding of both the
relationship between septic shock and hemostatic dysfunction
and also methods to measure this interaction may allow timely
intervention and prevention of hemostatic dysfunction with
subsequently improved outcomes.
Plasma-based assays including prothrombin (PT),
international standardized ratio (INR), and activated partial
thromboplastin time (aPTT) have been traditionally used to
evaluate hemostatic potential. These tests have several significant
limitations: (1) they do not account for the cellular contribution
to hemostasis by platelets and red blood cells (RBC); (2) they
cannot quantify hypercoagulable states; and (3) they attempt to
evaluate in isolation two limited components of the complex
enzymatic cascades that result in a continuous balance between
clot formation and breakdown. Because of these limitations,
investigators and clinicians have begun to study and use
viscoelastic assays such as thromboelastography (TEG) to
evaluate hypo- and hypercoagulable states in both research and
clinical arenas (10). Theoretically, by evaluating the combined
contributions of the cellular and plasma protein components
on hemostasis, viscoelastic monitoring may provide a more
accurate reflection of hemostatic capacity. A recent Cochrane
review indicated that the application of a viscoelastic-guided
transfusion strategy reduces the amount of bleeding, decreases
the incidence of renal injury and may decrease mortality
(11). The use of TEG to monitor hemostasis is frequent in
some pediatric clinical areas, including cardiovascular surgery,
extracorporeal membrane oxygenation (ECMO), and trauma
(12–15). However, broader use of TEG remains controversial
with unclear indications in patients outside of those with active
bleeding or who are receiving systemic anticoagulation.
While there is limited adult and neonatal data on TEG
based evaluation of sepsis-induced coagulopathy (SIC) (16–23),
to date, there is no published pediatric data. In this study of
children with severe sepsis or septic shock, we aimed to describe
in detail the incidence of hemostatic dysfunction as defined
using TEG variables. We then explored the relationship between
both TEG variables and TEG defined hemostatic dysfunction
and (1) development of new or progressive multiple organ
dysfunction syndrome (NPMODS), (2) development of shock,
and (3) changes in markers of endothelial injury and cytokines
involved in coagulation activation. Lastly, we explored whether
TEG variables, endothelial injury markers, and cytokine levels
could be used to create a predictive model for the development
of shock and NPMODS.
MATERIALS AND METHODS
All patients between ages 6-months and 14- years admitted
to a pediatric intensive care unit (PICU) in a large tertiary
care children’s hospital were screened on a daily basis over
an 18 month period from March 2012 through September
2013. Patients >6-months of age were excluded due to the
amount of blood that needed to be sampled. Patients above
14 years of age were arbitrarily excluded since they may
be more similar to adults regarding their hemostatic system.
Patients with severe sepsis or septic shock as defined by
Goldstein et al., were eligible for enrollment (1). Additional
inclusion criteria were a projected PICU stay of at least another
72 h as predicted by their attending intensivist and absence
of restrictions on life-sustaining therapies. Patients with pre-
existing hyper- or hypocoagulable disorders, pre-existing liver
failure severe enough to cause baseline hypocoagulable states
on conventional coagulation assays, or hemoglobinopathies
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were excluded. Patients receiving systemic anticoagulation or
antiplatelet medications were also excluded.
Study enrollment (study day 0) occurred when the patient
first met criteria for severe sepsis or septic shock. The following
calendar day was assigned as study day 1. Following signed
informed consent by the child’s guardian, demographic data
including age, sex and weight were collected. The severity of
illness scores including PIM-2 [Pediatric Index of Mortality-
2] and PRISM-3 [Pediatric Risk of Mortality Score-3]) were
calculated from the first 24 h of PICU admission. Daily PELOD
(Pediatric Logistic Organ Dysfunction) scores were calculated
for each day of study participation (study days 0–5). Patients
who developed new organ failure per standard definitions (1)
during the study period were characterized as having New or
Progressive Multiple Organ Dysfunction Syndrome (NPMODS).
Shock (inadequate oxygen delivery to meet demand) was defined
by a lactic acid concentration of ≥2 mmol/L (24–28). Lactate
values were drawn from a free flowing central intravenous
catheter or an arterial catheter. We constructed three study
groups for comparison in this study; severe sepsis without shock
or NPMODS (–S/–NPMODS), severe sepsis with shock but no
NPMODS (+S/–NPMODS), severe sepsis with both shock and
NPMODS (+S/+NPMODS).
The study period was a total of 7 days. Daily laboratory
assessment consisted of complete blood count, chemistry profile,
blood gas, lactate, standard coagulation panel (PT, INR, aPTT,
fibrinogen, and D-Dimer), and kaolin-activated TEG. If the
patient remained in the PICU for longer than 5 days, only
interventions and organ dysfunction were noted for an additional
two days. Hospital mortality and PICU length of stay (LOS)
were recorded.
Coagulation state (hyper or hypocoagulable) was assigned
based on all TEG parameters [Reaction (R) time, K time, α
angle, maximum amplitude (MA), and G value] (29, 30). We
applied our institution’s laboratory department defined normal
TEG ranges for each parameter. TEG-defined coagulation states
were assigned as normal, hypercoagulable, hypocoagulable, or
mixed states for each study day. Normal coagulation state was
defined as having all TEG parameters for that individual sample
falling within normal range. Hypercoagulable state was defined
as having one or more TEG parameters from that day’s sample
demonstrating rapid clot initiation (short R time) or formation
(short K time or high α angle) or abnormally high clot strength
(high MA or high G). Hypocoagulable state was defined as one
or more TEG parameters demonstrating delayed clot initiation
(long R time), delayed clot formation (long K time or low α
angle), or below normal clot strength (low MA or low G). Mixed
state was defined as having an individual TEG panel with some
parameters suggesting increased hemostatic function and others
consistent with suppressed hemostatic function.
We also measured selected cytokines involved in activation
of the coagulation system including interleukin (IL)-1β, IL-6,
IL-10, and TNF-α and markers of endothelial injury including
intercellular adhesion molecule (ICAM) and vascular cell
adhesion molecule (VCAM) by enzyme-linked immunosorbent
assay (ELISA) method using commercial available kits on
samples drawn during study days 1–5.
Statistical analysis was performed using SPSS v24 (IBM
headquarter, New York, NY). Standard descriptive, Chi-square,
Fisher’s Exact, Wilcoxon Rank Sum, and Kruskal Wallis tests
were performed as appropriate. Spearman’s correlation test was
conducted to determine the correlation between continuous
variables. Due to the exploratory nature of this pilot project,
we chose not to adjust for multiple comparisons when setting
our p-value threshold for statistical significance. For plotting
the correlation graphs, we removed outliers (>3 standard
deviation) on Y-axis. A receiver operating characteristic curve
was created to establish predictive models for the development of
NPMODS based on hemostatic variables and cytokine levels. The
Washington University School of Medicine Institutional Review
Board approved this protocol.
RESULTS
We enrolled 28 patients with a median age of 7.3 years
[interquartile range (IQR) of 4.4–11.4] with male predominance
18 (64%) who met criteria for severe sepsis in the PICU. One
patient did not have serum lactate levels obtained and was
excluded from the groups’ comparisons and correlation analysis.
Of 27 patients with severe sepsis, 12 (44%) demonstrated neither
shock nor NPMODS (–S/–NPMODS), 8 (30%) had shock but
not NPMODS (+S/–NPMODS) patients, and 7 (26%) had both
shock and NPMODS (+S/+NPMODS). Age, PRISM III scores,
PIM-2 scores, and PELOD scores (day 1–5) were similar in
the three study groups. Patients with +S/+NPMODS compared
to those with –S/–NPMODS and +S/–NPMODS had a longer
median PICU length of stay of 48 days (IQR, 24.5–66) vs. 6.5 days
(3.2–17.2) and 8 days (4–18), p= 0.007, as well as a longermedian
hospital length of stay of 80 days (46.5–111) vs. 11 days (7–28.5)
and 14 days (7–27), p = 0.017. Presenting organ dysfunction at
the time of meeting severe sepsis criteria were similar in all three
groups with respiratory and cardiovascular failure being the most
frequently observed. See Table 1. All study subjects survived to
hospital discharge.
On blood samples drawn daily during the five study days, a
hypercoagulable state occurred most commonly in 73% (94/129),
followed by hypocoagulable state in 7.8% (10/129) samples, and
mixed coagulation state in 1.5 (2/129) of samples based on TEG
parameters. In contrast, hypocoagulable state based on standard
coagulation parameters, occurred in 66% (98/148) of samples.
Normal coagulation measurements occurred in 18% (23/129) of
samples based on TEG parameters and 34% (50/148) of samples
based on standard coagulation parameters.
In the seven patients with +S/+NPMODS, we found
increased hypocoagulable state based on lowest platelet count,
highest INR, lowest fibrinogen level, lowest TEG-MA and lowest
TEG-G value during the first 5 study days compared to those
with –S/–NPMODS and +S/–NPMODS as reported in Table 2.
There was no difference in the markers of fibrinolysis including
D-dimer level and TEG lysis at 30min between these groups.
Also, we found no difference between markers of endothelial
injury (ICAM andVCAM) among these groups. On evaluation of
specific cytokines, during the first 5 study days we found higher
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Central Nervous 1 1 1
Respiratory 9 7 6
Cardiovascular 11 8 7
Hepatic 2 1 2
Renal 0 0 1















Data are presented as median (interquartile range) except as noted; p-value <0.05 was considered significant. aPRISM – Predictive Risk of Mortality.
bPIM – Predictive Index of Mortality.
cPELOD – Pediatric Logistic Organ Dysfunction Score.
dOrgan failure, as defined by Goldstein, et al. (1), at the time of meeting severe sepsis criteria. Data presented as either median (range) or as number of patients with the specific organ
system failure.
e PICU LOS – Pediatric Intensive Care Unit Length of Stay.
fS/NPMODS – Shock/New or Progressive Multi Organ Dysfunction Syndrome.
peak serum level of IL-6 and IL-10 in +S/+NPMODS patients
compared to –S/–NPMODS and+S/–NPMODS patients.
Peak lactate concentration during the first five study days
had significant correlation with the standard coagulation tests
of platelet count (ρ −0.543, p = 0.003), INR (ρ 0.631, p
= 0.001), and fibrinogen level (ρ −0.460, p = 0.016), but
no correlation with aPTT (ρ 0.254, p = 0.25) or D-dimer
concentration (ρ 0.256, p = 0.16) (Supplement Figures 1a–d).
For the viscoelastic testing, peak lactate correlated with longest
TEG-R (ρ 0.485, p = 0.01, longest TEG-K (ρ 0.395, p =
0.04), lowest TEG- MA (ρ −0.528, p = 0.005), lowest TEG-
G (ρ −0.542, p = 0.004) (Figure 1A), and highest TEG lysis
(ρ −0.460, p = 0.01) (Supplement Figures 2a–d). Also, peak
lactate concentration correlated with peak IL-6 level (ρ 0.526,
p = 0.008) and peak IL-10 level (ρ 0.652, p < 0.0001), but
had no correlation with VCAM (ρ 0.279, p = 0.16), ICAM
(ρ 0.283, p = 0.15), IL-1β (ρ 0.142, p = 0.48), and TNF-α (ρ
0.348, p = 0.076) (Supplement Figures 3a–d). Of all viscoelastic
parameters, only lowest TEG -G value had moderate correlation
with peak IL-10 (ρ −0.442, p = 0.019) and peak VCAM (ρ
−0.495, p = 0.007) in the first five study days as illustrated
in Figures 1B,C.
On receiver operating characteristic curve analysis to
discriminate patients with +S/+NPMODS, a cut off value
for TEG- G of <7 dynes/cm2 had sensitivity of 81% and
specificity of 85.7% with area under the curve (AUC) of
0.776 and 95% confidence interval (CI) of 0.574–0.977 (p
= 0.03). Similarly, a peak IL-6 cut off value of >1,247
pg/dL had sensitivity of 80% and specificity of 90% with
AUC, CI of 0.840, 0.556–1.000 (p = 0.021). A peak IL-10
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Data are presented as median (interquartile range); p-value <0.05 was considered significant.
aWBC – White Blood Cells Count.
bHb – Hemoglobin.
c INR – International Normalized Ratio.
daPTT – Activated Thromboplastin Time.
eTEG – Thromboelastography.
fMA – Maximum Amplitude.
gVCAM – Vascular Cell Adhesion Molecule.
h ICAM – Intercellular Adhesion Molecule.
i IL – Interleukin.
jTNF – Tissue Necrosis Factor.
kS/NPMODS – Shock/New or Progressive Multi Organ Failure Syndrome.
cut off value of >48 pg/dL had sensitivity of 85.5% and
specificity of 71.4% with AUC, CI of 0.782, 0.547–1.000
(p = 0.028). Among platelet count, INR, TEG-G value,
IL-6 and IL-10, a combination of TEG-G value and IL-6
value could best discriminate patients with +S/+NPMODS
(AUC 0.979 and 95% CI of 0.929–1.000, p < 0.0001) based
on non-parametric assumption in our cohort as illustrated
in Figure 2.
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FIGURE 1 | Correlation of lowest TEG- G value with (A) peak lactate
concentration (B) peak IL-10 concentration, and (C) peak VCAM
concentration in the first five study days. A non-parametric Spearman’s
correlation coefficient was calculated with p-value <0.05 was
considered significant.
FIGURE 2 | Receiver operating characteristic (ROC) curve to discriminate
children with severe sepsis who developed shock with NPMODS
(+S/+NPMODS). Worst TEG- G cut off value of <7 dynes/cm2 had sensitivity
of 81% and specificity of 85.7% with area under the curve (AUC) of 0.776 and
95% CI of 0.574–0.977 (p = 0.03). Peak IL-6 cut off value of >1,247 pg/dL
had sensitivity of 80% and specificity of 90% with AUC of 0.840 and 95% CI of
0.556–1.000 (p = 0.021) to discriminate patients with +S/+NPMODS. A
combination of TEG-G value and IL-6 value could best discriminate patients
with +S/+NPMODS (AUC 0.979 and 95% CI of 0.929–1.000, p < 0.0001) in
children with severe sepsis.
DISCUSSION
To our knowledge, this is the first study to report TEG based
evaluation of hemostatic dysfunction in children with severe
sepsis. Our results indicate that hypercoagulability is the more
common coagulation state in children with severe sepsis based
on TEG, in contrast to more frequent hypocoagulability state
observed on standard coagulation assays. However, children
with severe sepsis and +S/+NPMODS are relatively more
hypocoagulable based on both TEG and standard coagulation
assays compared to children with severe sepsis and –S/–
NPMODS or +S/–NPMODS. TEG- G value, a marker of the
overall clot formation and stability, decreased with increasing
peak lactate concentration, a surrogate marker of oxygen
delivery. Among all variables measured, a combination of TEG-
G (cut off value of <7 dynes/cm2) and IL-6 level (cut off value
of >48 pg/dL) could best distinguish children with severe sepsis
and+S/+NPMODS in our cohort.
Previous reports have described the varying incidence of
hypercoagulable, normal, and hypocoagulable states in adults
and neonates with severe sepsis (1–4, 16–23). The incidence
of hypercoagulability has been reported in 30–100% of adults
with severe sepsis (31). However, although hypercoagulability is
frequently described in the early stages of sepsis, development
of a hypocoagulable state on TEG is consistently associated with
increased morbidity and mortality in adults and neonates with
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severe sepsis (16–18, 22, 23, 29). Clot strength and formation
are largely preserved despite prolongation in clot formation and
impairment of fibrinolysis on rotational thromboelastrometry
(ROTEM) assays, another viscoelastic assay, in adults with
septic shock (23). The kinetics of clot growth utilizing ROTEM
assays have been shown to strongly correlate with mortality
in adults with severe sepsis (22). Our results suggest that
the hypocoagulable state, demonstrated by either delayed clot
formation with longer TEG-R and TEG-K times or lower final
clot strength with lower TEG-MA and TEG-G values, is more
closely associated with higher lactate levels.
Another advantage of TEG is its ability to measure hyper-
fibrinolysis. Contrary to other etiologies of DIC in critically
ill children, such as trauma, burn, major surgery (7, 12, 32),
where hyper-fibrinolysis is frequent (usually defined as >3%
lysis at 30min), patients with severe sepsis frequently show
normal or impaired fibrinolysis on TEG (23, 33, 34). As
hypo-fibrinolysis is not easy to detect and quantify based on
standard viscoelastic and coagulation assays. In a small adult
study, a modified urokinase-TEG assay was used to unmask
impaired fibrinolysis, the authors reported about half of the
patients had impaired fibrinolysis on urokinase-TEG (UK-
TEG Lysis at 30min was lower [70 (29–90) in adults with
sepsis vs. 91 (89–93) % in healthy adults, p < 0.0001]; also
impaired fibrinolysis was associated with increased markers
of cellular damage, morbidity, and mortality (33). We also
found a negative correlation between the degree of fibrinolysis
at 30min on TEG and peak lactate concentration in our
cohort, and none of the patients had hyper-fibrinolysis (>3%
lysis at 30min). These findings support the hypothesis of
impaired fibrinolysis in children with severe sepsis, which
potentially exacerbate with shock. We need more sensitive and
specific assays to quantify fibrinolysis dysfunction in children
with sepsis.
Higher pro-inflammatory IL-6 and anti-inflammatory IL-
10 levels have been associated with DIC and development
of MODS in sepsis (35–37). IL-6 alone or in combination
with other inflammatory markers such as procalcitonin, C-
reactive protein, and IL-10 has been shown to identify
patients with sepsis in both children and neonates (38, 39).
IL-6 has been shown to activate various components of
hemostasis including endothelial cells, platelets, coagulation
proteins and RBCs (35). In an ex-vivo model, the addition
of IL-6 led to rapid clot formation based on a decrease in
TEG-R time but drop in overall clot formation velocity and
strength suggestive of alternation in fibrin complexes from
fibrinogen and interaction of cellular components such as
platelets and RBC in the clot formation (37). In contrast,
IL-10 production is increased as a counter to the pro-
inflammatory effects of cytokines such as IL-6 and TNF-α. IL-
10 has been shown to prevent endotoxin-induced coagulation
via inhibition of tissue factor activation (40, 41). In our cohort,
higher peak IL-6 and IL-10 levels were associated with the
+S/+NPMODS patients, and these patients also developed
the hypocoagulable state. The interplay between pro-IL-6 and
anti-IL-10 inflammatory cytokines seen in our +S/+NPMODS
patients may be a reflection of the ongoing balance between
pro- and anti-coagulant stimulants. Thus, our finding of
increased hypocoagulable measures in our sickest patients
using viscoelastic testing may reflect the counterbalancing
effects between IL-10 and IL-6 on overall coagulation status.
Viscoelastic tests could give insight into the overall balance
between pro-and anti-inflammatory cytokines on sepsis-induced
hemostatic dysfunction.
There have also been reports of increased expression of
markers of endothelial injury in this patient population. In
adults with severe sepsis, ICAM and VCAM levels were
found to be elevated in those who developed MODS (42).
Similarly, higher levels of ICAM and VCAM were reported in
children with severe sepsis and MODS compared to healthy
controls and those with severe sepsis only (43). Interestingly
in our cohort, we did not find differences between ICAM and
VCAM among different groups and only limited associations
between VCAM and TEG-G. This may have been related
to differences in patient age, disease severity, etiology of
infection, and sample size. Thus, further investigation into
the interplay between endothelial injury and hemostatic state
are needed.
This study had many limitations. First, the patients were
enrolled only after fulfilling criteria for severe sepsis, and only
if the attending physician predicted a PICU length of stay of at
least 72 h. Our patient cohort was thus biased toward those who
were perceived to be more severely ill at initial diagnosis of severe
sepsis or septic shock. Also, our patient cohort was somewhat
older than the typical PICU demographic. This approach also
introduced a non-standard length of time between fulfillment
of severe sepsis criteria and the time of study day 1 labs that
precludes the ability to comment on the timing of onset of
hemostatic changes in this study population. Another weakness
of this study lies in the non-standardized number of total days
of study enrollment. Laboratory studies and data were only
collected during the patient’s PICU stay, leading to missing data
in seven patients, none of whom developed NPMODS. Lastly,
because of a small sample size we were unable to account for
some important confounding factors including the degree of
fluid resuscitation, type and source of infection, age, and use of
blood products.
Despite these limitations, in this exploratory study, we were
able to demonstrate novel relationships between TEG variables
and the development of shock in this population of severe
sepsis patients. Furthermore, we found a novel association
between TEG parameters and markers of immune function
but only limited correlation between TEG parameters and
markers of endothelial injury. These findings provide hypotheses
generating findings on hemostatic dysfunction based on TEG,
correlation of hemostatic dysfunction with lactate, and immune
and endothelial alternations in children with severe sepsis.
CONCLUSION
This exploratory analysis of hemostasis dysfunction on
thromboelastography in children with severe sepsis suggests that
while hypercoagulability is more common, a hypocoagulable
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state is associated with shock and NPMODS. In addition,
thromboelastography abnormalities are also associated with
alterations in immune and endothelial factors in this population.
Larger studies are needed to examine the interactions between
oxygen delivery, hemostasis, immune and endothelial function
in children with severe sepsis.
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Supplement Figure 1 | Correlation of peak lactate concentration with
conventional coagulation assays including (a) lowest platelet count, (b) highest
INR value, (c) lowest fibrinogen concentration, and (d) highest D-dimer
concentration. A non-parametric Spearman’s correlation coefficient was
calculated with p-value <0.05 considered significant.
Supplement Figure 2 | Correlation of peak lactate concentration with TEG
variables including (a) lowest TEG-R time, (b) longest TEG-K time, (c) lowest
TEG-MA value, and (d) highest TEG-lysis percentage. A non-parametric
Spearman’s correlation coefficient was calculated with p-value <0.05
considered significant.
Supplement Figure 3 | Correlation of peak lactate concentration with markers of
immune and endothelial activation including (a) peak IL-6 concentration, (b) peak
IL-10 concentration, (c) peak VCAM concentration, and (d) peak ICAM
concentration. A non-parametric Spearman’s correlation coefficient was
calculated with p-value <0.05 considered significant.
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